Search
Search
Maintaining consistent outcomes across regions becomes increasingly complex as programs advance from development to manufacturing. Differences in raw material sourcing, equipment configuration, service execution, and supply chain coordination can introduce variability, delay timelines, and increase operational risk. Site equivalency addresses these challenges by aligning manufacturing, service, and supply chain operations within a global manufacturing network. Through harmonized sites, shared quality systems, and coordinated planning, Thermo Fisher Scientific supports reliable execution across global bioprocessing workflows, so teams can plan, scale, and transfer with greater confidence.
Site equivalency is achieved by aligning core elements, such as raw materials, procedures, processes, equipment, testing, and quality systems, across manufacturing sites.
Harmonized supply chain management sites allow coordinated planning, inventory strategy, logistics oversight, and risk mitigation across manufacturing and service locations. Centralized planning frameworks connect sourcing status, material availability, and distribution logistics within a unified operating model. Global coordination enables flexible inventory strategies, such as safety stock positioning and vendor-managed inventory programs.
Support bioprocessing workflows through service centers operating under aligned quality systems, facility standards, and compliance frameworks. Standardized procedures, specialists, and controlled environments, including ISO-8 classified cleanrooms where applicable, enable consistent service execution across regions.
Service centers extend equivalent operational practices across the global network, including locations in:
For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.